Primary Care Clinics in Wood Dale, IL Accepting Medicare
4 Primary Care Clinics found. Showing 1 - 4
 Dr Mark E Pappadopoli M D P C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 236 E Irving Park Rd, Suite C, Wood Dale, IL 60191 Phone: 630-860-5160 Fax: 630-860-5262 |
5 Pillars S.c. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 404 W Irving Park Rd, Wood Dale, IL 60191 Phone: 773-544-5306 |
Physicians Pro Care Llc General Practice Medicare: Not Enrolled in Medicare Practice Location: 311 N Walnut Ave, Wood Dale, IL 60191 Phone: 847-304-9506 |
Wood Dale Family Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 199 S Addison Rd, Suite 108, Wood Dale, IL 60191 Phone: 630-616-7223 Fax: 630-616-7224 |
News Archive
Orexigen Therapeutics reports net loss of $18.6 million in Q3 2013
Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced business and financial results for the third quarter ended September 30, 2013.
Glanbia Nutritionals, ChromaDex sign LOI for pTeroPure
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, and marketer of its branded patent-pending pterostilbene, pTeroPure, announced today it has signed a letter of intent with Glanbia Nutritionals (NA), Inc., a global ingredient and micronutrient premix company, for the distribution of pTeroPure. Glanbia Nutritionals will serve as the primary distributor of pTeroPure in North America.
Nanotechnology provides novel solutions against zoonotic viruses
Therefore, scientists functionalize nanoparticles to act against these pathogenic viruses in a clinical strategy. In a recent review published in the journal Microbial Pathogenesis, researchers look at the novel solutions against zoonotic viruses provided by nanotechnology.
Testing reveals 11 percent of people in Geneva infected with SARS-CoV-2
Now, a team of researchers at Geneva University Hospitals has found that less than 11 percent of the population in Geneva has contracted the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Their research is published in the journal The Lancet.
Two oncogenes work together to sustain population of cells in lung squamous cell carcinoma
Patients with a common form of lung cancer — lung squamous cell carcinoma — have very few treatment options. That situation may soon change.
› Verified 5 days ago